Botulinum toxin treatment
AssigneeIpsen Biopharm Ltd.
InventorsChris Dott, John Batchelor, Pierre Bernard D'Arbigny, Roland Cherif-Cheikh
Life of this patent
Estimating the term…
Loading patent…
AssigneeIpsen Biopharm Ltd.
InventorsChris Dott, John Batchelor, Pierre Bernard D'Arbigny, Roland Cherif-Cheikh
Estimating the term…
A liquid or semi-solid formulation of botulinum toxin for the preparation of a medicament intended to treat a disorder characterized by bladder spasms (e.g. urinary incontinence due to unstable bladder or unstable detrusor sphincter, voiding complications due to detrusor overactivity or unstable detrusor sphincter, urinary retention secondary to spastic sphincter or hypertrophied bladder neck and neurogenic bladder dysfunction secondary to Parkinson's disease, spinal cord injury, stroke or multiple sclerosis or characterized by a spasm reflex), wherein said medicament is for administration by infusion into the bladder or by other methods that do not involve injection into the bladder wall.
A method of treating a bladder spasm disorder in a patient comprising administering an effective amount of botulinum toxin to a patient in need thereof, the method comprising spreading a solid, semi-solid or liquid formulation of botulinum toxin onto an outer wall of a balloon;
Dependencies are inferred from the claim text.